Mario Cazzola

Mario Cazzola is Honorary Professor of Respiratory Medicine at the University of Rome ‘Tor Vergata’, Rome, Italy. He founded Therapeutic Advances in Respiratory Diseases and served as the Editor-in-Chief for Pulmonary Pharmacology & Therapeutics, and for COPD – Research and Practice. He is Deputy Editor for Respiratory Medicine, Section Editor for Frontiers in Drug Safety and Regulation, and an Associate Editor for Respiratory Research, Current Research in Pharmacology and Drug Discovery, Clinical Investigation, and The Open Respiratory Medicine Journal, and an Editor for British Journal of Pharmacology. He is the author or co-author of almost 754 scientific papers. His H-index is 74. According to Expertscape (November 2022), he is the top-rated expert in COPD, obstructive lung diseases and bronchodilator agents worldwide. He was the Chairman of the Airway Pharmacology and Treatment Group and Co-chairman of the ERS/ATS Task Force “Outcomes for COPD pharmacological trials: from lung function to biomarkers”. He has received the 2015 Lifetime Achievement Award from the same scientific society. He was a member of the steering committee of the Airway Disorders Network and served as Governor of the Italian Chapter at the American College Chest Physicians.

He is the Chairman of the Southern Europe Chapter at Interasma, and the Chair of the Med COPD Forum. His research has mainly been focused on the pharmacology of airway diseases, particularly the use of bronchodilators and obstructive lung diseases.